Intracellular localization of proteasomal degradation of a viral antigen

被引:186
作者
Antón, LC
Schubert, U
Bacík, I
Princiotta, MF
Wearsch, PA
Gibbs, J
Day, PM
Realini, C
Rechsteiner, MC
Bennink, JR
Yewdell, JW
机构
[1] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA
[2] Univ Hamburg, Heinrich Pette Inst, Hamburg, Germany
[3] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA
[4] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA
关键词
antigen presentation; molecular chaperone; nuclear proteins proteolysis; ubiquitin/immunology; proteasome;
D O I
10.1083/jcb.146.1.113
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To better understand proteasomal degradation of nuclear proteins and viral antigens we studied mutated forms of influenza virus nucleoprotein (NP) that misfold and are rapidly degraded by proteasomes. In the presence of proteasome inhibitors, mutated NP (dNP) accumulates in highly insoluble ubiquitinated and nonubiquitinated species in nuclear substructures known as promyelocytic leukemia oncogenic domains (PODs) and the microtubule organizing center (MTOC). Immunofluorescence revealed that dNP recruits proteasomes and a selective assortment of molecular chaperones to both locales, and that a similar (though less dramatic) effect is induced by proteasome inhibitors in the absence of dNP expression. Biochemical evidence is consistent with the idea that dNP is delivered to PODs/MTOC in the absence of proteasome inhibitors. Restoring proteasome activity while blocking protein synthesis results in disappearance of dNP from PODs and the MTOC and the generation of a major histocompatibility complex class I-bound peptide derived from dNP but not NP. These findings demonstrate that PODs and the MTOC serve as sites of proteasomal degradation of misfolded dNP and probably cellular proteins as well, and imply that antigenic peptides are generated at one or both of these sites.
引用
收藏
页码:113 / 124
页数:12
相关论文
共 39 条
  • [1] Antón LC, 1998, J IMMUNOL, V160, P4859
  • [2] Bercovich B, 1997, J BIOL CHEM, V272, P9002
  • [3] Bogyo M, 1997, BIOPOLYMERS, V43, P269, DOI 10.1002/(SICI)1097-0282(1997)43:4<269::AID-BIP2>3.0.CO
  • [4] 2-T
  • [5] VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES
    CHAKRABARTI, S
    BRECHLING, K
    MOSS, B
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3403 - 3409
  • [6] The ubiquitin-proteasome pathway: on protein death and cell life
    Ciechanover, A
    [J]. EMBO JOURNAL, 1998, 17 (24) : 7151 - 7160
  • [7] Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
    Cummings, CJ
    Mancini, MA
    Antalffy, B
    DeFranco, DB
    Orr, HT
    Zoghbi, HY
    [J]. NATURE GENETICS, 1998, 19 (02) : 148 - 154
  • [8] DANIEL MT, 1993, BLOOD, V82, P1858
  • [9] SUMO-1 modification of IκBα inhibits NF-κB activation
    Desterro, JMP
    Rodriguez, MS
    Hay, RT
    [J]. MOLECULAR CELL, 1998, 2 (02) : 233 - 239
  • [10] A NOVEL MACROMOLECULAR STRUCTURE IS A TARGET OF THE PROMYELOCYTE-RETINOIC ACID RECEPTOR ONCOPROTEIN
    DYCK, JA
    MAUL, GG
    MILLER, WH
    CHEN, JD
    KAKIZUKA, A
    EVANS, RM
    [J]. CELL, 1994, 76 (02) : 333 - 343